IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,931,368 | -33.1% | 9,891,000 | -33.1% | 0.12% | -33.0% |
| Q1 2023 | $14,853,728 | -39.0% | 14,791,000 | -34.2% | 0.18% | -30.2% |
| Q4 2022 | $24,353,056 | -15.4% | 22,491,000 | -21.5% | 0.25% | -18.7% |
| Q3 2022 | $28,803,000 | -1.7% | 28,655,000 | +3.2% | 0.31% | +5.4% |
| Q2 2022 | $29,301,000 | +16.6% | 27,767,000 | +24.7% | 0.29% | +20.0% |
| Q1 2022 | $25,136,000 | +1.8% | 22,267,000 | +0.2% | 0.24% | +6.5% |
| Q4 2021 | $24,685,000 | -1.3% | 22,227,000 | +4.7% | 0.23% | +6.5% |
| Q3 2021 | $25,018,000 | +0.4% | 21,227,000 | 0.0% | 0.22% | +13.7% |
| Q2 2021 | $24,906,000 | +5.9% | 21,227,000 | 0.0% | 0.19% | -4.5% |
| Q1 2021 | $23,520,000 | -1.1% | 21,227,000 | 0.0% | 0.20% | +13.7% |
| Q4 2020 | $23,790,000 | +14.1% | 21,227,000 | 0.0% | 0.18% | -5.4% |
| Q3 2020 | $20,856,000 | – | 21,227,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 12,388 | $12,458,000 | 0.88% |
| SHENKMAN CAPITAL MANAGEMENT INC | 13,818,000 | $13,900,000 | 0.78% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 3,500,000 | $3,510,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 28,655,000 | $28,803,000 | 0.31% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,334,000 | $12,434,000 | 0.28% |
| CSS LLC/IL | 5,000,000 | $5,024,000 | 0.24% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 22,700,000 | $22,913,000 | 0.14% |
| Jefferies Group LLC | 7,347,000 | $7,413,724 | 0.06% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 26,000 | $26,000 | 0.04% |
| Calamos Advisors LLC | 7,500,000 | $7,542,000 | 0.03% |